Women's Health 2012

Published 01/02/2012

Author: Nicholas Hall's Reports

Despite women living longer than men by an average of four years, they report more illnesses, with greater vulnerability to ailments such as arthritis, osteoporosis, migraines and Irritable Bowel Syndrome.

Additionally, there are therapeutic areas specific to women (such as VYI treatments, EHC, menopause and period pain) which have a growing market globally.

Women also tend to be the primary purchaser of OTCs in the contemporary family unit, and these factors all make this report such an essential read for OTC marketers who want to find out more about the market for women’s OTCs.

This report examines all areas relating to women’s health, offering insight into trends and developments, assessing the size of the market and profiling successful brands.

Focusing on all of the above key factors, this report examines some of the most successful examples of marketing OTCs to women, as well as briefly profiling those OTC players with a dedicated focus on women’s health. Finally, it assesses the scope for growth and new niches among women’s OTCs, including potential switches.